BROOKE TEAL: Open Payments
NPI 1427093731 · JASPER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,657 in 80 payments from 29 companies in 2025. Trend: 2023 $2,101 · 2024 $2,795 · 2025 $2,657
Food & beverage: $1,525Long term medical supply or device loan: $1,000Education: $132
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $1,096 |
| PFIZER INC. | 8 | $180 |
| Janssen Biotech, Inc. | 3 | $156 |
| Merck Sharp & Dohme LLC | 4 | $118 |
| Exelixis Inc. | 4 | $108 |
| GlaxoSmithKline, LLC. | 3 | $80 |
| GENZYME CORPORATION | 3 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| ABBVIE INC. | 3 | $70 |
| Incyte Corporation | 3 | $68 |
Products named: KISQALI, KEYTRUDA, CABOMETYX, DARZALEX, OJJAARA, SARCLISA, ORGOVYX, REBLOZYL.
Industry payments across GA — which companies pay providers there.
